Ecuador vs Guyana: Antiretroviral therapy coverage for PMTCT
Ecuador
85.0%
in 2024
Guyana
84.0%
in 2024
Ecuador rank
35th
Guyana rank
37th
Antiretroviral therapy coverage for PMTCT over time
- Ecuador
- Guyana
How they compare
Ecuador currently reports 85.0% against 84.0% in Guyana, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Guyana ahead.
Ecuador ranks 35th and Guyana ranks 37th of 84 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.8% | 38.9% | 22.1% | Guyana |
| 2010s | 45.6% | 74.6% | 29.0% | Guyana |
| 2020s | 78.0% | 80.0% | 2.0% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ecuador or Guyana?
- Ecuador, at 85.0% against 84.0% in Guyana as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ecuador and Guyana?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Guyana?
- 25 years are reported by both, from 2000 to 2024.
- How do Ecuador and Guyana rank globally for antiretroviral therapy coverage for pmtct?
- Ecuador ranks 35th and Guyana ranks 37th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).